Charles Schwab Investment Management Inc Bluebird Bio, Inc. Transaction History
Charles Schwab Investment Management Inc
- $519 Billion
- Q2 2024
A detailed history of Charles Schwab Investment Management Inc transactions in Bluebird Bio, Inc. stock. As of the latest transaction made, Charles Schwab Investment Management Inc holds 554,183 shares of BLUE stock, worth $277,091. This represents 0.0% of its overall portfolio holdings.
Number of Shares
554,183
Previous 522,458
6.07%
Holding current value
$277,091
Previous $668,000
18.71%
% of portfolio
0.0%
Previous 0.0%
Shares
28 transactions
Others Institutions Holding BLUE
# of Institutions
162Shares Held
79.9MCall Options Held
525KPut Options Held
634K-
Black Rock Inc. New York, NY15.4MShares$7.72 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA10.3MShares$5.15 Million0.0% of portfolio
-
Ameriprise Financial Inc Minneapolis, MN6.39MShares$3.2 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny5.15MShares$2.57 Million0.0% of portfolio
-
Pictet Asset Management Sa Geneva 73, V84.67MShares$2.33 Million0.02% of portfolio
About bluebird bio, Inc.
- Ticker BLUE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 77,121,800
- Market Cap $38.6M
- Description
- bluebird bio, Inc., a biotechnology company, researches, develops, and commercializes transformative gene therapies for severe genetic diseases. Its product candidates for severe genetic diseases include betibeglogene autotemcel for the treatment of transfusion-dependent ß-thalassemia; lovotibeglogene autotemcel for the treatment of sickle cell ...